# Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

> **NCT07034326** · PHASE2,PHASE3 · RECRUITING · sponsor: **Kong Fanming** · enrollment: 405 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Electroacupuncture
- Immune Checkpoint Inhibitors

## Interventions

- **OTHER:** Electroacupuncture combined with immunotherapy
- **DRUG:** Zilongjin tablet combined with immunotherapy
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT07034326
- **Lead sponsor:** Kong Fanming
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 405 (ESTIMATED)
- **Last updated:** 2025-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034326, "Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07034326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*